NICE greenlights use of cladribine for those with less severe form of the disease
Trials found that 93% of patients did not need blood transfusions after treatment, which has been described as a ‘historic moment’ for people with thalassaemia
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
